BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28719811)

  • 21. Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis.
    Huang YJ; Huang TW; Lin FH; Chung CH; Tsao CH; Chien WC
    J Thorac Oncol; 2017 May; 12(5):782-790. PubMed ID: 28214559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
    Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
    J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients.
    Grantzau T; Overgaard J
    Radiother Oncol; 2016 Dec; 121(3):402-413. PubMed ID: 27639892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second cancer, breast cancer, and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy: a national registry study.
    Ye JC; Yan W; Christos P; Nori D; Chao KS; Ravi A
    Clin Breast Cancer; 2015 Feb; 15(1):54-9. PubMed ID: 25223278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second Malignancy Probabilities in Patients With Breast Cancer Treated With Conventional Versus Hypofractionated External Beam Radiation Therapy in the Adjuvant Setting.
    Patel TA; Jain B; Cho HL; Corti C; Vapiwala N; Chino F; Leeman JE; Dee EC
    Clin Oncol (R Coll Radiol); 2024 Mar; 36(3):183-192. PubMed ID: 38184401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
    Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study.
    Lange JM; Takashima JR; Peterson SM; Kalapurakal JA; Green DM; Breslow NE
    Cancer; 2014 Dec; 120(23):3722-30. PubMed ID: 25348097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of second malignancies among patients treated with proton versus photon radiation.
    Chung CS; Yock TI; Nelson K; Xu Y; Keating NL; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):46-52. PubMed ID: 23778197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
    Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
    Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG).
    Grantzau T; Mellemkjær L; Overgaard J
    Radiother Oncol; 2013 Jan; 106(1):42-9. PubMed ID: 23395067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcoma as a second malignancy after treatment for breast cancer.
    Yap J; Chuba PJ; Thomas R; Aref A; Lucas D; Severson RK; Hamre M
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1231-7. PubMed ID: 11955733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up.
    Casper AC; Parsons MW; Chipman J; Burt LM; Suneja G; Maurer KA; Gaffney DK
    Gynecol Oncol; 2021 Aug; 162(2):454-460. PubMed ID: 34092413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Angiosarcoma following breast-conserving therapy].
    Hogewind BF; Boutkan HB; de Jager-Nowak HK; Merkus JW
    Ned Tijdschr Geneeskd; 2004 May; 148(20):995-7. PubMed ID: 15181725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy.
    Yi M; Cormier JN; Xing Y; Giordano SH; Chai C; Meric-Bernstam F; Vlastos G; Kuerer HM; Mirza NQ; Buchholz TA; Hunt KK
    Ann Surg Oncol; 2013 May; 20(5):1514-21. PubMed ID: 23224829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secondary Angiosarcoma of the Breast after Breast-conserving Therapy].
    Wiebringhaus P; Gröger A; Menke H
    Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):134-8. PubMed ID: 25412244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
    Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
    Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.